Tuesday, August 19, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reiterates Buy Rating on Navitas Semiconductor with Positive Outlook

Elaine Mendonca by Elaine Mendonca
March 2, 2024
in Breaking News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On March 2, 2024, analyst Kevin Cassidy from Rosenblatt reiterated a positive outlook on Navitas Semiconductor (NASDAQ: NVTS), maintaining a Buy rating with a $12 price target. The average price target for Navitas Semiconductor stands at $11.00, with a high forecast of $12.00 and a low forecast of $10.00, indicating a potential 90.64% increase from the current price of $5.77.

With a consensus rating of Strong Buy from 4 Wall Street analysts, Navitas Semiconductor is poised for growth. The company’s upcoming earnings report is scheduled for February 29, 2024. Navitas Semiconductor specializes in designing gallium nitride power integrated circuits for a wide range of applications, including mobile devices, consumer electronics, data centers, solar energy systems, electric vehicles, and more.

NVTS Stock Price Drops 7.82% on March 2, 2024: After-Hours Trading Shows Potential Interest

On March 2, 2024, NVTS stock experienced a significant drop in its price, closing at $5.66, which was a decrease of $0.48 or 7.82% from the previous market close. Despite the drop in price during regular trading hours, NVTS saw a slight uptick in after-hours trading, with the stock rising $0.20. This after-hours movement suggests that there may be some investor interest in NVTS at its current price level. Investors should consider broader market conditions, relevant news, and events that may have impacted NVTS’s stock performance on March 2nd. It is important to conduct thorough research and analysis before making any investment decisions.

NVTS Stock Analysis: Revenue Surges But Net Income Declines

On March 2, 2024, NVTS stock experienced significant fluctuations in its financial performance. The total revenue for the company stood at $79.46 million for the past year, showing an increase of 113.34% compared to the previous year. However, the total revenue for the last quarter was $26.06 million, indicating an increase of 18.56% compared to the previous quarter.

Despite the increase in total revenue, NVTS reported a net income of -$146.47 million for the past year, which represents a decrease of 298.16% compared to the previous year. The net income for the last quarter was -$32.58 million, showing a decrease of 533.28% compared to the previous quarter.

Furthermore, the earnings per share (EPS) for NVTS were reported as -$0.86 for the past year, reflecting a decrease of 269.74% compared to the previous year. The EPS for the last quarter was -$0.18, indicating a decline of 549.88% compared to the previous quarter.

These financial indicators suggest that NVTS stock has faced challenges in its profitability and financial performance over the past year and quarter. Investors and analysts may need to closely monitor the company’s operations and financial strategies to assess its future growth potential and stock performance. It is important for investors to conduct thorough research and analysis before making any investment decisions related to NVTS stock.

Tags: NVTS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ Chart Down

Options Activities and Market Sentiment Surrounding Trade Desk

Food Producers Stock Market Today

Title Beyond Meat Inc Faces Delay in Annual Report Filing for 2023 Fiscal Year

Biotechnology Stock Bull Market

Humacyte HUMA Faces Significant Drop After 402 Million Public Offering

Recommended

Real Estate Investment Stock Market Today

Revolutionizing Real Estate NARs Historic Agreement to Reduce Commissions and Settle Lawsuits

1 year ago
Finance_Commercial

BMO Capital Raises Gap Price Target to 18

1 year ago

NLS Pharmaceutics Receives Notice of Deficiency from Nasdaq

2 years ago
EEFT stock news

Symmetry Partners LLC Acquires Shares of The Interpublic Group of Companies, Inc. showing insight into the company’s potential profitability

2 years ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • ETF
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE ADSK ALB AMD AMZN AVGO BA C CCL CELH COIN COST CRWD CTVA DELL DFS DIS DLR DLTR DWAC GM GRFS IBM INTC JPM KSS LLY META MSFT NFLX NVDA NVO ORCL PARA PLTR PLUG QCOM SMCI TGT TSLA UNH VZ
No Result
View All Result

Highlights

Warren Buffett Bets Big on Troubled Healthcare Giant UnitedHealth

Johnson & Johnson Shares Gain Momentum on Strong Earnings and Medical Breakthroughs

Is Physical Gold the Ultimate Hedge? VanEck Merk Gold Trust Offers Unique Exposure

Investor Spotlight Falls on PROS Holdings as Pivotal Talks With Northland Commence

Block Shatters Bond Market Expectations with $2.2 Billion Raise

TRI Pointe Shares Defy Weak Earnings With Unexpected Rally

Trending

Iovance Stock
Stocks

Iovance Secures Landmark Canadian Approval for Breakthrough Cancer Therapy

by Dieter Jaworski
August 19, 2025
0

Shares of Iovance Biotherapeutics surged in after-hours trading following a pivotal regulatory win in Canada. Health Canada...

iShares MSCI Poland ETF Stock

Poland’s Economic Momentum Fuels Growth Prospects for iShares MSCI Poland ETF

August 19, 2025
Livent Stock

Rio Tinto’s Lithium Power Play: How a $6.7B Acquisition Reshapes the Battery Materials Race

August 19, 2025
Unitedhealth Stock

Warren Buffett Bets Big on Troubled Healthcare Giant UnitedHealth

August 19, 2025
Johnson & Johnson Stock

Johnson & Johnson Shares Gain Momentum on Strong Earnings and Medical Breakthroughs

August 19, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Iovance Secures Landmark Canadian Approval for Breakthrough Cancer Therapy August 19, 2025
  • Poland’s Economic Momentum Fuels Growth Prospects for iShares MSCI Poland ETF August 19, 2025
  • Rio Tinto’s Lithium Power Play: How a $6.7B Acquisition Reshapes the Battery Materials Race August 19, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • ETF
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com